Sort by
Refine Your Search
-
all applicable University and departmental policies and procedures. The postdoc candidate is expected to: 1) Develop coarse-grained or mesoscopic models of dynamic DNA nanostructures and polymer-grafted
-
for interdisciplinary collaboration offered at Duke. The Postdoctoral Associate will be expected to prepare and publish first-authored articles in peer-reviewed scientific journals. Opportunities may be available
-
position is funded by multiple NIH projects, e.g., https://tinyurl.co m/ysxhmujvThe overall goal is to : (1) develop inference and dynamic prediction models using a wide variety of data, including clinical
-
conduct applied research and development in the area of microphysiological systems, tissue engineering, and stem cell biology. The majority of the candidate’s focus will be on developing and using stem
-
., https://tinyurl.com/yy8xwtoq , https://tinyurl.com/bhkr2mm5 , https://tinyurl.com/2f99j7df , and https://tinyurl.com/ysxhmujv The overall goal is to: (1) develop inference and dynamic prediction
-
of the lab. Position will conduct postdoctoral research related to the overall goals of the Silver lab to understand mechanisms of brain development, disease and evolution. DEFINITION: The Postdoctoral
-
expected to publish or prepare to publish the results of his or her research or scholarship during the period of the appointment. EXPECTATION: The conscientious discharge of research or scholarship
-
to state-of-the-art facilities. Join us in our mission to advance our understanding of alveolar development, homeostasis, regeneration, and pathology. Your valuable contributions will significantly impact
-
relevant experience(s) based on the job requirements. Responsibilities: · Manage, store, and analyze clinical research data · Conduct systematic literature reviews, develop hypotheses, critically think, and
-
cells with organoid culture, which will create novel pre-clinical disease models. 3.Identifying vulnerabilities in treatment-resistant epithelial cancers. 4.Developing novel therapies targeting oncogenic